Novel Small-Molecule Antidepressants

Description:
These potential antidepressant compounds have a novel mechanism of action – blockade of transporters for the neurotransmitters norepinephrine, serotonin, and dopamine. This novel “triple reuptake blockade” approach holds promise for a more effective and rapidly-acting antidepressant.
Patent Information:
Category(s):
Medical
Biotechnology
For Information, Contact:
Rob Whitehead
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9219
rwhitehead@vtip.org
Inventors:
Paul Carlier
Elliott Richelson
Keywords:
Pharmaceuticals & Biotechnology
© 2017. All Rights Reserved. Powered by Inteum